vs
Immunocore Holdings plc（IMCR）与ROGERS CORP（ROG）财务数据对比。点击上方公司名可切换其他公司
ROGERS CORP的季度营收约是Immunocore Holdings plc的1.9倍（$200.5M vs $104.5M），Immunocore Holdings plc同比增速更快（24.3% vs 5.2%），ROGERS CORP自由现金流更多（$1.1M vs $-35.5M），过去两年Immunocore Holdings plc的营收复合增速更高（21.7% vs -3.3%）
Immunocore是一家处于商业化阶段的全球生物技术企业，总部位于英国牛津郡，依托可溶性T细胞受体技术深耕生物药物的研发领域，其创新技术平台为肿瘤、感染性疾病、自身免疫性疾病等多领域的新药开发提供支撑。
罗杰斯公司是一家专注于特种工程材料研发生产的企业，总部位于美国亚利桑那州钱德勒市，其产品广泛应用于先进电子、移动通信、清洁能源、航空航天等多个高科技领域，为全球客户提供高性能材料解决方案。
IMCR vs ROG — 直观对比
营收规模更大
ROG
是对方的1.9倍
$104.5M
营收增速更快
IMCR
高出19.1%
5.2%
自由现金流更多
ROG
多$36.6M
$-35.5M
两年增速更快
IMCR
近两年复合增速
-3.3%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $104.5M | $200.5M |
| 净利润 | — | $4.5M |
| 毛利率 | 97.4% | 32.2% |
| 营业利润率 | -18.8% | — |
| 净利率 | — | 2.2% |
| 营收同比 | 24.3% | 5.2% |
| 净利润同比 | — | 421.4% |
| 每股收益（稀释后） | $-0.61 | $0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IMCRROG
| Q1 26 | — | $200.5M | ||
| Q4 25 | $104.5M | $201.5M | ||
| Q3 25 | $103.7M | $216.0M | ||
| Q2 25 | $98.0M | $202.8M | ||
| Q1 25 | $93.9M | $190.5M | ||
| Q4 24 | $84.1M | $192.2M | ||
| Q3 24 | $80.2M | $210.3M | ||
| Q2 24 | $75.4M | $214.2M |
净利润IMCRROG
| Q1 26 | — | $4.5M | ||
| Q4 25 | — | $4.6M | ||
| Q3 25 | $-177.0K | $8.6M | ||
| Q2 25 | $-10.3M | $-73.6M | ||
| Q1 25 | $5.0M | $-1.4M | ||
| Q4 24 | — | $-500.0K | ||
| Q3 24 | $8.7M | $10.7M | ||
| Q2 24 | $-11.6M | $8.1M |
毛利率IMCRROG
| Q1 26 | — | 32.2% | ||
| Q4 25 | 97.4% | 31.5% | ||
| Q3 25 | 99.5% | 33.5% | ||
| Q2 25 | 98.9% | 31.6% | ||
| Q1 25 | 99.1% | 29.9% | ||
| Q4 24 | 99.6% | 32.1% | ||
| Q3 24 | 99.4% | 35.2% | ||
| Q2 24 | 97.7% | 34.1% |
营业利润率IMCRROG
| Q1 26 | — | — | ||
| Q4 25 | -18.8% | 3.5% | ||
| Q3 25 | -6.9% | 7.3% | ||
| Q2 25 | -15.2% | -33.3% | ||
| Q1 25 | -3.9% | -0.2% | ||
| Q4 24 | -23.1% | -6.6% | ||
| Q3 24 | -10.6% | 6.9% | ||
| Q2 24 | -21.2% | 5.3% |
净利率IMCRROG
| Q1 26 | — | 2.2% | ||
| Q4 25 | — | 2.3% | ||
| Q3 25 | -0.2% | 4.0% | ||
| Q2 25 | -10.5% | -36.3% | ||
| Q1 25 | 5.4% | -0.7% | ||
| Q4 24 | — | -0.3% | ||
| Q3 24 | 10.9% | 5.1% | ||
| Q2 24 | -15.4% | 3.8% |
每股收益（稀释后）IMCRROG
| Q1 26 | — | $0.25 | ||
| Q4 25 | $-0.61 | $0.20 | ||
| Q3 25 | $0.00 | $0.48 | ||
| Q2 25 | $-0.20 | $-4.00 | ||
| Q1 25 | $0.10 | $-0.08 | ||
| Q4 24 | $-0.47 | $-0.04 | ||
| Q3 24 | $0.17 | $0.58 | ||
| Q2 24 | $-0.23 | $0.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $864.2M | $195.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $381.0M | $1.2B |
| 总资产 | $1.1B | $1.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IMCRROG
| Q1 26 | — | $195.8M | ||
| Q4 25 | $864.2M | $197.0M | ||
| Q3 25 | $892.4M | $167.8M | ||
| Q2 25 | $882.8M | $157.2M | ||
| Q1 25 | $837.0M | $175.6M | ||
| Q4 24 | $820.4M | $159.8M | ||
| Q3 24 | $901.3M | $146.4M | ||
| Q2 24 | $859.6M | $119.9M |
总债务IMCRROG
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $438.7M | — | ||
| Q2 24 | $452.5M | — |
股东权益IMCRROG
| Q1 26 | — | $1.2B | ||
| Q4 25 | $381.0M | $1.2B | ||
| Q3 25 | $396.6M | $1.2B | ||
| Q2 25 | $388.5M | $1.2B | ||
| Q1 25 | $378.5M | $1.3B | ||
| Q4 24 | $360.7M | $1.3B | ||
| Q3 24 | $377.8M | $1.3B | ||
| Q2 24 | $359.1M | $1.3B |
总资产IMCRROG
| Q1 26 | — | $1.4B | ||
| Q4 25 | $1.1B | $1.4B | ||
| Q3 25 | $1.1B | $1.4B | ||
| Q2 25 | $1.1B | $1.5B | ||
| Q1 25 | $1.0B | $1.5B | ||
| Q4 24 | $1.0B | $1.5B | ||
| Q3 24 | $1.1B | $1.5B | ||
| Q2 24 | $1.0B | $1.5B |
负债/权益比IMCRROG
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.16× | — | ||
| Q2 24 | 1.26× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-32.7M | $5.8M |
| 自由现金流经营现金流 - 资本支出 | $-35.5M | $1.1M |
| 自由现金流率自由现金流/营收 | -34.0% | 0.5% |
| 资本支出强度资本支出/营收 | 2.8% | 2.3% |
| 现金转化率经营现金流/净利润 | — | 1.29× |
| 过去12个月自由现金流最近4个季度 | $-15.1M | $70.1M |
8季度趋势，按日历期对齐
经营现金流IMCRROG
| Q1 26 | — | $5.8M | ||
| Q4 25 | $-32.7M | $46.9M | ||
| Q3 25 | $-4.5M | $28.9M | ||
| Q2 25 | $26.0M | $13.7M | ||
| Q1 25 | $435.0K | $11.7M | ||
| Q4 24 | $-14.0M | $33.7M | ||
| Q3 24 | $21.1M | $42.4M | ||
| Q2 24 | $23.5M | $22.9M |
自由现金流IMCRROG
| Q1 26 | — | $1.1M | ||
| Q4 25 | $-35.5M | $42.2M | ||
| Q3 25 | $-5.2M | $21.2M | ||
| Q2 25 | $25.6M | $5.6M | ||
| Q1 25 | $137.0K | $2.1M | ||
| Q4 24 | $-17.5M | $18.3M | ||
| Q3 24 | $20.3M | $25.2M | ||
| Q2 24 | $23.1M | $8.8M |
自由现金流率IMCRROG
| Q1 26 | — | 0.5% | ||
| Q4 25 | -34.0% | 20.9% | ||
| Q3 25 | -5.0% | 9.8% | ||
| Q2 25 | 26.1% | 2.8% | ||
| Q1 25 | 0.1% | 1.1% | ||
| Q4 24 | -20.9% | 9.5% | ||
| Q3 24 | 25.3% | 12.0% | ||
| Q2 24 | 30.7% | 4.1% |
资本支出强度IMCRROG
| Q1 26 | — | 2.3% | ||
| Q4 25 | 2.8% | 2.3% | ||
| Q3 25 | 0.7% | 3.6% | ||
| Q2 25 | 0.4% | 4.0% | ||
| Q1 25 | 0.3% | 5.0% | ||
| Q4 24 | 4.3% | 8.0% | ||
| Q3 24 | 1.0% | 8.2% | ||
| Q2 24 | 0.4% | 6.6% |
现金转化率IMCRROG
| Q1 26 | — | 1.29× | ||
| Q4 25 | — | 10.20× | ||
| Q3 25 | — | 3.36× | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.09× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.42× | 3.96× | ||
| Q2 24 | — | 2.83× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
